Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation

European Journal of Haematology

Volumn 81, Issue 3, 2008, Pages 226-235

  Chen, Guanghua ^a   Wu, Depei ^a   Wang, Yi ^a   Cen, Jiannong ^a   Feng, Yufeng ^a   Sun, Aining ^a   Tang, Xiaowen ^a   Chang, Huirong ^a   Zhu, Ziling ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Immune reconstitution; Interleukin 15; Natural killer cell; T cell receptor chain; Thymic output

Indexed keywords

RECOMBINANT INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 2;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL 6 MOUSE; CANCER MODEL; CANCER MORTALITY; CELL ISOLATION; CONTROLLED STUDY; DONOR; DRUG EFFECT; DRUG EFFICACY; EX VIVO STUDY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; IMMUNE RESPONSE; INOCULATION; LEUKEMIA; LEUKEMIA CELL; LEUKEMIA RELAPSE; LYMPHOCYTE COUNT; LYMPHOID TISSUE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SPLEEN CELL; T LYMPHOCYTE; THROMBOCYTOPOIESIS; WEIGHT REDUCTION;

EID: 49349097899     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01108.x     Document Type: Article

References (26)

1. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990 75: 555 62.
2. Kim DH, Sohn SK, Lee NY, et al. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. Eur J Haematol 2005 75: 299 308.
3. Mielke S, Nunes R, Rezvani K, et al. A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique. Blood 2008 111: 4392 402.
4. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002 295: 2097 100.
5. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006 6: 584 94.
6. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998 396: 690 5.
7. Douek DC, Vescio RA, Betts MR, et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T cell reconstitution. Lancet 2000 355: 1875 81.
8. Ding SL, Chu JX, Zhao JM, Chu Y, Jiang L, Ying HG. Establishment and biological characterization of a transplantable BALB/c mouse erythroblastic leukemia model. Chin J Hematol 1998 19: 638 41.
9. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Crawford JM, Ferrara JL. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996 88: 3230 9.
10. Johnston SL, Wettstein PJ. Spectratyping of TCR expressed by CTL-infiltrating male antigen (HY)-disparate allografts. J Immunol 1998 160: 3393 402.
11. Broers A, Sluijs SJ, Spits H, van der Holt B, Löwenberg B, Braakman E, Cornelissen JJ. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 2003 102: 1534 40.
12. Li YQ, Chen SH, Yang LJ, Yin QS, Geng SX, Wu XL, Schmidt CA, Przybylski GK. TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells. Transplant Immunol 2007 18: 151 8.
13. Cooper MA, Bush JE, Fehniger TA, Van Deusen JB, Waite RE, Liu Y, Aguila HL, Caligiuri MA. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002 100: 3633 8.
14. Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005 174: 1213 21.
15. Alpdogan O, Eng JM, Muriglan SJ, et al. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 2005 105: 865 73.
16. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T-cell regeneration occurs via antigen-driven expansion of peripheral T-cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996 156: 4609 16.
17. Lewin SR, Heller G, Zhang L, et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 2002 100: 2235 42.
18. Lee CK, Gingrich RD, deMagalhaes-Silverman M, Hohl RJ, Joyce JK, Scott SD, Wen BC, Schlueter A. Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 1999 5: 15 27.
19. Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, Velardi A, Blazar BR. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002 100: 3825 7.
20. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Müller W, Di Santo JP. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003 101: 4887 93.
21. Luhm J, Brand J, Koritke P, Höppner M, Kirchner H, Frohn C. Large-scale generation of natural killer lymphocytes for clinical application. J Hematother Stem Cell Res 2002 11: 651 7.
22. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu JL, Shlomchik MJ, Emerson SG. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999 285: 412 5.
23. Morecki S, Yacovlev E, Gelfand Y, Vilensky A, Slavin S. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect. Biol Blood Marrow Transplant 2004 10: 40 8.
24. Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005 105: 3051 7.
25. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001 97: 1458 66.
26. Hochberg EP, Chillemi AC, Wu CJ, et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 2001 98: 1116 21.